HemaSphere
(Jun 2022)
PB2219: A REAL-WORLD EXPERIENCE WITH HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON
- A. Inati,
- M. Sabbagh,
- C. Al Alam,
- A. Al Kheir,
- Z. Massouh,
- R. Demachkie,
- C. Ojaimy,
- N. Dani,
- A. Siddiqui,
- R. Rajat Adhikary,
- B. Lynch,
- A. Srivastava
Affiliations
- A. Inati
- 1 School of Medicine, Lebanese American University
- M. Sabbagh
- 2 Novartis, Beirut, Lebanon
- C. Al Alam
- 3 American Center for Psychiatry and Neurology, Abu Dhabi, United Arab Emirates
- A. Al Kheir
- 4 Saudi German Hospital, Dammam, Saudi Arabia
- Z. Massouh
- 5 Department of Pediatrics, NINI Hospital, Tripoli
- R. Demachkie
- 6 School of Medicine, Lebanese American University, Byblos, Lebanon
- C. Ojaimy
- 5 Department of Pediatrics, NINI Hospital, Tripoli
- N. Dani
- 7 Novartis
- A. Siddiqui
- 8 Novartis Pharma AG, Basel, Switzerland
- R. Rajat Adhikary
- 9 Novartis, Hyderabad, India
- B. Lynch
- 10 Novartis, Dublin, Ireland
- A. Srivastava
- 9 Novartis, Hyderabad, India
- DOI
-
https://doi.org/10.1097/01.HS9.0000851704.30692.ea
- Journal volume & issue
-
Vol. 6
pp.
2089
– 2090
WeChat QR code